BioVie Inc.
BIVI
$0.8408
$0.04766.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.84% | -21.81% | -23.39% | -28.50% | -21.46% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -46.10% | -46.04% | -28.62% | -11.59% | 25.55% |
| Operating Income | 46.10% | 46.04% | 28.62% | 11.59% | -25.55% |
| Income Before Tax | 43.90% | 49.43% | 36.09% | 26.29% | -4.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.90% | 49.43% | 36.09% | 26.29% | -4.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.90% | 49.43% | 36.09% | 26.29% | -4.93% |
| EBIT | 46.10% | 46.04% | 28.62% | 11.59% | -25.55% |
| EBITDA | 46.34% | 46.27% | 28.76% | 11.65% | -25.72% |
| EPS Basic | 66.67% | 61.22% | 49.30% | 41.14% | 20.31% |
| Normalized Basic EPS | 68.79% | 62.91% | 50.57% | 42.35% | 20.31% |
| EPS Diluted | 66.56% | 61.18% | 49.26% | 41.44% | 20.28% |
| Normalized Diluted EPS | 68.79% | 62.91% | 50.57% | 42.35% | 20.31% |
| Average Basic Shares Outstanding | 123.26% | 49.16% | 39.11% | 31.42% | 35.21% |
| Average Diluted Shares Outstanding | 123.26% | 49.16% | 39.11% | 31.42% | 35.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |